Science Resources RSS Feeds
|
 |
 |
 |
Cancer Current Events | Cancer News
|
| Page
1 of
79 |
1562 Results |
|
|
|
Sort By:
Page Views | Date |
Who gets cancer treatment, and who completes it?
Cancer treatment is now very effective in many cases, yet not all patients with cancer are referred and not all complete their treatment programme. This has puzzled cancer specialists who have wondered if psychological factors might influence their decision and has led to research carried out by Dr Stan Lindsay from the Institute of Psychiatry in... view more... (2002-11-13)
Comment from Professor Nick Lemoine, Director of Imperial Cancer Research Fund's Molecular Oncology Unit at the Hammersmith Hospital, in response to US research* that has linked breast cancer to a virus:
Comment from Professor Nick Lemoine, Director of Imperial Cancer Research Fund's Molecular Oncology Unit at the Hammersmith Hospital, in response to US research* that has linked breast cancer to a virus: view more (1999-08-11)
PROSTATE CANCER SERIES (p 859)
A four-week series about prostate cancer-the third most common cancer in men worldwide, and the leading male cancer in Europe and North America-begins in this week's issue of THE LANCET. The first article, by Henrik Grönberg of Umea University, Sweden, assesses the epidemiology of prostate cancer, and examines the impact of genetic and... view more... (2003-03-05)
Family history of breast cancer does not increase risk of womb cancer
A family history of breast cancer does not increase a woman`s chances of developing womb cancer, finds a 20-year study in the Journal of Medical Genetics. Cancers of the lining of the womb (endometrium) and breast share some of the same reproductive, hormonal, and lifestyle risk factors. The evidence for a genetic link between the two types of... view more... (2002-11-01)
Breast cancer drug receives FDA approval
A new use for the breast cancer drug Herceptin was approved by the FDA yesterday, a move that means more treatment options for the 25 percent of breast cancer patients with early-stage HER-2 positive breast cancer. view more (2006-11-20)
Chemotherapy and tamoxifen reduce risk of second breast cancer
Among breast cancer patients, both chemotherapy and tamoxifen independently reduced the risk of developing a second cancer in the other breast, according to a study published online December 25 in the Journal of the National Cancer Institute. The risk reduction persisted for at least 10 and 5 years, respectively. view more (2007-12-26)
Women smokers have higher risk of lung cancer than men smokers, though lower lung cancer death rate
Women who smoke appear to be more susceptible to lung cancer than men who smoke, though women smokers have a lower rate of lung cancer-related death. view more (2006-07-12)
Increased ovarian cancer risk not found in women with breast cancer family history
Women with a strong family history of breast cancer but who don't have breast cancer genetic mutations can now be reassured that they are not at increased risk for ovarian cancer. view more (2005-09-21)
Women without regular medical care at increased risk of ovarian cancer
In North America, ovarian cancer is the second most common gynecological cancer and is the leading cause of death among women with gynecological cancer. The high mortality is in part due to the difficulty of detecting and diagnosing this condition at an early stage. view more (2007-03-27)
Breast asymmetry predicts breast cancer
Women who go on to develop breast cancer tend to have breasts that are less symmetrical than women who don't develop the cancer. view more (2006-03-20)
New gene silencing therapy for cervical cancer
Researchers at The University of Queensland's (UQ) Centre for Immunology and Cancer Research (CICR), based at the Princess Alexandra Hospital, have pioneered a new approach for the treatment of cervical cancer. view more (2005-11-17)
Increased levels of Muellerian-inhibiting substance could mean greater breast cancer risk
Women with increased levels of Müllerian inhibiting substance (MIS), best known for regulating in utero sexual differentiation in boys, may be at a greater risk for breast cancer. view more (2009-10-12)
Media Registration: Europe`s largest breast cancer conference to be held in Barcelona
3rd European Breast Cancer Conference (EBCC-3) Palau de Congressos de Catalunya, Barcelona, Spain 19-23 March 2002 ABOUT EBCC-3"¦ * More than 3000 clinicians, scientists and patient advocates will attend. * Presentations will review new developments in molecular biology, epidemiology, prevention, diagnosis, treatment, psycho-social... view more... (2001-12-04)
Cancer Research UK supports additional TroVax phase II trial in colorectal cancer
Oxford BioMedica announced today that Cancer Research UK (CRUK) has agreed to conduct and sponsor an open label Phase II trial with Oxford BioMedica's leading cancer immunotherapy product, TroVax®, in colorectal cancer patients who have liver metastases. The decision by CRUK follows extensive review of the successful Phase I/II data of TroVax... view more... (2003-08-28)
Estrogen-progestin menopausal hormone therapy and risk of lobular and tubular breast cancer
Estrogen-progestin menopausal hormone therapy is associated with a more than two-fold higher relative risk of developing lobular cancer or tubular cancer than of developing ductal cancer. view more (2006-02-17)
Taking aim at mysterious DNA structures in the battle against cancer
Designers of anti-cancer drugs are aiming their arrows at mysterious chunks of the genetic material DNA that may play a key role in preventing the growth and spread of cancer cells, according to an article in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine. view more (2009-11-05)
Does public information about cancer screening do more harm than good?
Researchers at Imperial Cancer Research Fund have overturned claims that information provided to the public as part of a cancer screening programme increases people's anxiety about the disease and worries them unnecessarily. Their work is published today in the British Medical Journal*. view more (1999-10-13)
High rates of skin cancer among airline pilots
Rates and types of cancer were assessed in 458 pilots, 265 of whom flew the national Icelandic airline across European and transAtlantic routes. These were then compared with the rates of cancer expected to develop in the population as a whole, gathered from data supplied by the national cancer registry, according to age. view more (2000-02-14)
Improving understanding of cell behaviour in breast cancer
The invasion and spread of cancer cells to other parts of the body, known as metastasis, is a principal cause of death in patients diagnosed with breast cancer. view more (2008-07-16)
PREOPERATIVE RADIOTHERAPY IMPROVES OUTCOME IN RECTAL CANCER (PP 1285, 1291)
Preoperative radiotherapy reduces risk of local recurrence and death from rectal cancer, conclude authors of a systematic overview published in this week's issue of The Lancet. There are different opinions about when it is best to give radiotherapy for rectal cancer. In Scandinavia, the Netherlands, and some other European countries, radiotherapy... view more... (2001-10-17)
|
|
| Page
1 of
79 |
1562 Results |
|
|
|
Sort By:
Page Views | Date |
|
|
